CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
119 hedge funds and large institutions have $510M invested in CTI BioPharma Corp. (DE) Common Stock in 2022 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 38 increasing their positions, 21 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
29% more funds holding
Funds holding: 92 → 119 (+27)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Holders
119
Holding in Top 10
6
Calls
$6.57M
Puts
$3.15M
Top Buyers
| 1 | +$57.2M | |
| 2 | +$24.5M | |
| 3 | +$13.4M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$10.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$9.15M |
Top Sellers
| 1 | -$5.99M | |
| 2 | -$5.19M | |
| 3 | -$4.03M | |
| 4 |
Renaissance Technologies
New York
|
-$3.99M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2.98M |